What are the common side effects of Crestor (rosuvastatin) vs Lipitor (atorvastatin)?
Both Crestor and Lipitor are statins, so they share many of the same side-effect patterns. The key differences are usually not the types of side effects, but how often they show up for a given person and how those risks relate to dose and other health factors.
Muscle problems (myopathy, aches, rare rhabdomyolysis)
For both drugs, muscle-related symptoms are a major concern:
- Muscle aches, weakness, or cramps can occur with either statin.
- Severe muscle injury is rare but serious (rhabdomyolysis), and risk rises with higher doses and certain interacting medicines or conditions.
In practice, Crestor and Lipitor are both managed with the same approach when muscle symptoms happen: stop or reduce the statin and check labs (often creatine kinase) if needed.
Liver enzyme elevations and what patients notice
Both Crestor and Lipitor can raise liver enzymes on blood tests. Patients typically do not feel mild enzyme increases, but clinicians monitor:
- Liver function tests during treatment (especially if symptoms suggest liver trouble).
Serious liver injury is uncommon for both, but the monitoring and “stop if significant abnormalities occur” approach is similar.
Digestive side effects and headache
Some people report non-serious effects such as:
- Nausea, constipation or diarrhea
- Headache
These are generally less prominent than muscle and liver monitoring issues, and they can happen with either medication.
Diabetes risk: is it higher with one?
Statins can increase blood sugar and slightly raise the risk of developing diabetes in some patients, especially those already at risk. Whether Crestor or Lipitor is more likely to push risk higher can depend on dose and patient factors, not just the brand.
Which one is more likely to cause side effects for a specific patient?
The likelihood of side effects often depends more on:
- Dose intensity (higher doses generally raise risk)
- Kidney or liver function
- Drug-drug interactions (some combinations increase statin levels)
- Age, low body weight, and existing conditions
So two patients on “equivalent” therapy may have different experiences even if they’re on different statins.
Drug interactions: where differences can matter
Side-effect risk can rise if either statin’s levels increase due to interacting medications. These interactions vary by statin and by the other drugs a patient takes, so the “which is safer?” question often comes down to a patient’s medication list (for example, certain antifungals, antibiotics, HIV medications, and some cardiac medicines).
What should you do if you get side effects after switching Crestor ↔ Lipitor?
If symptoms start after beginning or increasing a statin:
- Call the prescriber promptly, especially for severe muscle pain, dark urine, or unusual weakness.
- Ask whether you should stop the statin temporarily, get blood tests, or switch to a different statin or dose.
- Mention any new medications or supplements started around the same time, since interactions can be the trigger.
Can you reduce side effects by changing dose or timing?
Clinicians sometimes manage statin intolerance by:
- Lowering the dose and titrating up more slowly
- Trying a different statin (switching between Crestor and Lipitor is one common strategy)
- Checking for interactions and correcting reversible risk factors
The best plan depends on why you’re taking the statin (LDL lowering vs prior heart disease risk) and which side effects you’re having.
Sources and additional checking
I can’t cite side-effect rates or detailed comparative findings without the specific reference set you want (they’re not included in your prompt). If you share either (1) the exact side effects you’re concerned about (muscle aches? liver? GI?) or (2) the doses you’re taking, I can narrow the comparison to what matters most.
If you want, I can also look up patent/regulatory product pages and summarize labeled safety information using DrugPatentWatch.com for each drug: https://www.drugpatentwatch.com/ (no specific Crestor/Lipitor pages were provided in your message).
Sources
- https://www.drugpatentwatch.com/